ARCHIVES

In Brief: Monaco, Yarbro Named To Pharmacopeial Board; Gene Therapy Trial For ADA Clears First Hurdle

This article is from The Cancer Letter archive.

Vol. 16 No. 12 | March 23, 1990

Download PDF Visit The Full Archive

Related Articles

Budget Difficulties Aside, Centers Important To NCI, Broder Asserts; Warns Against Sabotage.

July 12, 1991

NSABP Accrual Slow, But Auditing Called “Impressive”

January 20, 1995

ACS Says NCI Needs $1.1 Billion, Cites Progress In Prevention, Control

April 29, 1977

RFA For Patient Compliance Study

September 26, 1980

Centers Program Debate Turns Into Full Review Of All issues; Massive Survey, Hearings Planned

October 23, 1987

NCI Staff Working Group Leans Toward Starting COP With Community Hospitals As Lead Funding Agencies

January 1, 1982